Trifluorothymidine Resistance Is Associated with Decreased Thymidine Kinase and Equilibrative Nucleoside Transporter Expression or Increased Secretory Phospholipase A2

O.H. Temmink; I.V. Bijnsdorp; H.J. Prins; N. Losekoot; A.D. Adema; K Smid; R.J. Honeywell; B. Ylstra; P.P. Eijk; M Fukushima; G.J. Peters

doi:10.1158/1535-7163.MCT-09-0932

Trifluorothymidine Resistance Is Associated with Decreased Thymidine Kinase and Equilibrative Nucleoside Transporter Expression or Increased Secretory Phospholipase A2

O.H. Temmink, I.V. Bijnsdorp, H.J. Prins, N. Losekoot, A.D. Adema, K Smid, R.J. Honeywell, B. Ylstra, P.P. Eijk, M Fukushima, G.J. Peters

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1047-1057
Journal	Molecular Cancer Therapeutics
Volume	9
Issue number	4
DOIs	https://doi.org/10.1158/1535-7163.MCT-09-0932
Publication status	Published - 2010

Access to Document

10.1158/1535-7163.MCT-09-0932

Cite this

Temmink, O. H., Bijnsdorp, I. V., Prins, H. J., Losekoot, N., Adema, A. D., Smid, K., Honeywell, R. J., Ylstra, B., Eijk, P. P., Fukushima, M., & Peters, G. J. (2010). Trifluorothymidine Resistance Is Associated with Decreased Thymidine Kinase and Equilibrative Nucleoside Transporter Expression or Increased Secretory Phospholipase A2. Molecular Cancer Therapeutics, 9(4), 1047-1057. https://doi.org/10.1158/1535-7163.MCT-09-0932

@article{94efb8e06ed34e9eb89819c05473fd12,

title = "Trifluorothymidine Resistance Is Associated with Decreased Thymidine Kinase and Equilibrative Nucleoside Transporter Expression or Increased Secretory Phospholipase A2",

author = "O.H. Temmink and I.V. Bijnsdorp and H.J. Prins and N. Losekoot and A.D. Adema and K Smid and R.J. Honeywell and B. Ylstra and P.P. Eijk and M Fukushima and G.J. Peters",

year = "2010",

doi = "10.1158/1535-7163.MCT-09-0932",

language = "Undefined/Unknown",

volume = "9",

pages = "1047--1057",

journal = "Molecular Cancer Therapeutics",

issn = "1535-7163",

publisher = "American Association for Cancer Research Inc.",

number = "4",

}

Temmink, OH, Bijnsdorp, IV, Prins, HJ, Losekoot, N, Adema, AD, Smid, K, Honeywell, RJ , Ylstra, B, Eijk, PP, Fukushima, M & Peters, GJ 2010, 'Trifluorothymidine Resistance Is Associated with Decreased Thymidine Kinase and Equilibrative Nucleoside Transporter Expression or Increased Secretory Phospholipase A2', Molecular Cancer Therapeutics, vol. 9, no. 4, pp. 1047-1057. https://doi.org/10.1158/1535-7163.MCT-09-0932

Trifluorothymidine Resistance Is Associated with Decreased Thymidine Kinase and Equilibrative Nucleoside Transporter Expression or Increased Secretory Phospholipase A2. / Temmink, O.H.; Bijnsdorp, I.V.; Prins, H.J. et al.

In: Molecular Cancer Therapeutics, Vol. 9, No. 4, 2010, p. 1047-1057.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Trifluorothymidine Resistance Is Associated with Decreased Thymidine Kinase and Equilibrative Nucleoside Transporter Expression or Increased Secretory Phospholipase A2

AU - Temmink, O.H.

AU - Bijnsdorp, I.V.

AU - Prins, H.J.

AU - Losekoot, N.

AU - Adema, A.D.

AU - Smid, K

AU - Honeywell, R.J.

AU - Ylstra, B.

AU - Eijk, P.P.

AU - Fukushima, M

AU - Peters, G.J.

PY - 2010

Y1 - 2010

U2 - 10.1158/1535-7163.MCT-09-0932

DO - 10.1158/1535-7163.MCT-09-0932

M3 - Article

C2 - 20371715

VL - 9

SP - 1047

EP - 1057

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

SN - 1535-7163

IS - 4

ER -